
Noncompetitive enzyme immunoassay (hetero‐two‐site enzyme immunoassay) for γ ‐melanocyte‐stimulating hormone ( γ ‐msh) and measurement of immunoreactive γ ‐msh in plasma of healthy subjects
Author(s) -
Yogi Yoshikuni,
Hashida Seiichi,
Ekman Rolf,
Setoguchi Toshiaki,
Ishikawa Eiji
Publication year - 1995
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.1860090611
Subject(s) - immunoassay , chemistry , enzyme , chromatography , melanocyte stimulating hormone , detection limit , conjugate , antibody , hormone , biochemistry , biology , mathematical analysis , mathematics , immunology
A noncompetitive enzyme immunoassay (hetero‐two‐site enzyme immunoassay) for γ ‐melanocyte‐stimulating hormone ( γ ‐MSH) was developed. γ ‐MSH (1–12) was biotiny‐lated, trapped onto an anti‐ γ ‐MSH (1–12) IgG‐coated polystyrene bead, eluted at pH 1 after washing to eliminate other biotiny‐lated substances, and measured using two streptavidin‐coated polystyrene beads and affinity‐purified anti‐ γ ‐MSH (1–12) Fab'‐per‐oxidase conjugate. The detection limit of γ ‐MSH (1–12) was 10–30 amol (16–48 fg)/assay and 130–400 fmol (210–630 pg)/L of plasma. There was little or only slight cross reaction with α‐MSH, b̃‐MSH, and γ 1‐MSH. By this immunoassay, the concentration and molecular size of immunoreactive γ ‐MSH in plasma of healthy subjects were examined, and the results were compared with those by competitive enzyme immunoassay. Immunoreactive γ ‐MSH measured by competitive enzyme immunoassay was a mixture of substances with high molecular weights (100–500 kDa), and its concentration was calculated to be 50–60 pmol/L using γ ‐MSH (1–12) as standard. Immunoreactive γ ‐MSH detected by the noncompetitive enzyme immunoassay after removal of high molecular weight substances was not homogeneous and smaller than γ ‐MSH (1–12), and its concentration was ∼ 1 pmol/L. The exact nature of these immunoreactive γ ‐MSHs remains to be elucidated. γ ‐MSH (1–12) added to plasma was degraded rapidly, and the concentration of γ ‐MSH (1–12) was very low, if any, in plasma of healthy subjects.